Abstract
BACKGROUND: Medications are frequently combined in the nebulizer cup, so it is important to determine their chemical and physical compatibility.
OBJECTIVE: To determine the chemical and physical compatibility of levalbuterol with ipratropium bromide, cromolyn sodium, acetylcysteine sodium, and budesonide.
METHODS: We mixed one dose of levalbuterol inhalation solution concentrate (1.25 mg/0.5 mL) with one dose of ipratropium bromide (0.5 mg/2.5 mL), cromolyn sodium (20 mg/2 mL), acetylcysteine sodium (1,000 mg/5 mL), or budesonide (0.5 mg/2 mL). Immediately after mixing the 2 drugs (time zero [T0]), and again after 30 min at room temperature (T30), we visually inspected the admixtures, measured their pH, and conducted high-pressure liquid chromatography (HPLC)..
RESULTS: There was no evidence of physical incompatibility with these drugs combinations. With all the admixtures, both drugs were chemically stable for at least 30-min. Admixture pH had not changed significantly at T30. Drug recovery was 93.2–102.6% of the initial or control values.
CONCLUSIONS: The 2-drug admixtures we studied were compatible for at least 30 min at room temperature.
- levalbuterol
- budesonide
- ipratropium bromide
- cromolyn sodium
- acetylcysteine sodium
- compatibility
- concentrate
- admixture
- asthma
- bronchial asthma
Footnotes
- Correspondence: Shaowei Ong PhD, Sepracor, 84 Waterford Drive, Marlborough MA 01752;, Email: shaowei.ong{at}sepracor.com.
Elizabeth Goodwin PhD presented a version of this paper at the annual meeting of the American Academy of Allergy, Asthma, and Immunology, held February 23-27, 2007, in San Diego, California.
This research was performed at and supported by Sepracor, Marlborough, Massachusetts. Support was also provided by ABC Laboratories, Columbia, Missouri. The authors report no other conflicts of interest related to the content of this paper.
- Copyright © 2008 by Daedalus Enterprises Inc.